FundedIQ
Biotechnology

Santa Ana Bio: Funding, Investors & Team (Sep 2026)

Santa Ana Bio is a biotechnology company that uses advanced cell profiling techniques to create precise biologics for autoimmune conditions. Their focus is on developing specific treatments for patients with autoimmune and inflammatory diseases through the use of multi-omics platforms and antibody engineering.

www.santaanabio.com LinkedIn Alameda, United States 11-50 employees
Biotechnology Health Care Medical Therapeutics B2B
Total raised
$125M
Rounds
1
Latest
Series B
Jun 2024

Santa Ana Bio has raised $125M across 1 funding round on record, the most recent a Series B of $125M announced in Jun 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Santa Ana Bio Company Profile and Key Stats

Total funding raised
$125M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$125M in Jun 2024
Employees
11-50
reported band
Headquarters
Alameda, United States

Latest funding round on record: Jun 2024.

Santa Ana Bio Funding Rounds

Date
Round
Amount
Series B
$125M

Santa Ana Bio Founders and Leadership Team

Name
Role
Contact
Danny Wells
Founder
Locked

Contact details for the Santa Ana Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Santa Ana Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
4,289
$30M

Santa Ana Bio's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Santa Ana Bio in Biotechnology and Alameda

Companies Similar to Santa Ana Bio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Santa Ana Bio Funding FAQs

What does Santa Ana Bio do?

Santa Ana Bio is a biotechnology company that uses advanced cell profiling techniques to create precise biologics for autoimmune conditions. Their focus is on developing specific treatments for patients with autoimmune and inflammatory diseases through the use of multi-omics platforms and antibody engineering.

How much funding has Santa Ana Bio raised?

Santa Ana Bio has raised $125M across 1 round on record. The most recent is a Series B of $125M announced in Jun 2024.

When did Santa Ana Bio last raise funding?

Santa Ana Bio's most recent funding round on record is a Series B of $125M, announced in Jun 2024.

Who founded Santa Ana Bio?

FundedIQ lists Danny Wells (Founder) at Santa Ana Bio.

Where is Santa Ana Bio headquartered?

Santa Ana Bio is based in Alameda, California, United States.

How many employees does Santa Ana Bio have?

Santa Ana Bio is in the 11-50 employee band.

How does Santa Ana Bio's funding compare to other Biotechnology startups?

Santa Ana Bio's latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Santa Ana Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Santa Ana Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.